HRSA 340B Rebate Pilot — Both Comment Windows Closed; AHA, ASHP, NACHC, WHA All Filed Formal Opposition
Both HRSA 340B Rebate Model comment windows are now closed: the main RFI deadline (April 20) and the burden-focused ICR deadline (April 27). AHA, ASHP, NACHC, and WHA all filed formal opposition arguing the rebate model — converting upfront 340B discounts into back-end rebates — would cost FQHCs and hospitals over $1B/year, jeopardize access, and force compliance burden benefiting Second Sight Solutions (the third-party vendor) and drug manufacturers.
Pilot would cover up to 25 drugs from 13 manufacturers with Medicare Drug Price Negotiation Program agreements. Decision now rests with HHS following the Maine District Court vacating the original notice in February 2026.
Industry-wide opposition is the strongest unified safety-net front in 340B's 30-year history.
Primary source
AHA / NACHC / ASHP / WHAFQHC Talent. (2026, April 27). HRSA 340B Rebate Pilot — Both Comment Windows Closed; AHA, ASHP, NACHC, WHA All Filed Formal Opposition. Primary source: AHA / NACHC / ASHP / WHA. Retrieved June 15, 2026, from https://www.fqhctalent.com/intel/hrsa-340b-rebate-rfi-icr-comments-closed-april-2026
More in Lobbying & Advocacy
Jun 5
California's November Ballot Becomes a Health-Care Battleground: Hospital Industry's Union-Spending Counter-Measure Qualifies, Joining SEIU-UHW's Two Clinic Measures — With a June 25 Deal Deadline
May 22
California Hospital Association Warns FQHC Closures Will Drive Up ED Visits — First Time Hospital Lobby Publicly Backs FQHC Sustainability
May 19
SEIU-UHW 90% Patient-Care Mandate QUALIFIES for Nov 3, 2026 California Ballot — Existential FQHC Governance Fight Now Confirmed
Apr 27
CalChamber 'Affordable California' Files Nearly 1 Million Signatures for November 2026 Ballot — Counter to SEIU-UHW 90% Spend Initiative